Department of Psychiatry and Psychotherapy, Institute of Psychiatric Phenomics and Genomics (IPPG) Medical Center of the University of Munich Supported by the Deutsche Forschungsgemeinschaft (DFG) 5. Münchener Kraepelin-Symposium and Symposium of the Clinical Research Group 241 Recovery in psychoses: reserved for a subgroup? Causes and consequences KLINIKUM DER UNIVERSITÄT MÜNCHEN KLINIK FÜR PSYCHIATRIE UND PSYCHOTHERAPIE INSTITUT FÜR PSYCHIATRISCHE PHÄNOMIK UND GENOMIK CAMPUS INNENSTADT 9 CME Punkte
Transcript
Department of Psychiatry and Psychotherapy, Institute of Psychiatric Phenomics and Genomics (IPPG)
Medical Center of the University of Munich
Supported by the Deutsche Forschungsgemeinschaft (DFG)
5. Münchener Kraepelin-Symposium and Symposium of the Clinical Research
Group 241Recovery in psychoses: reserved for a subgroup?
Causes and consequences
KLINIKUMDER UNIVERSITÄT MÜNCHEN
KLINIK FÜR PSYCHIATRIE UND PSYCHOTHERAPIE
INSTITUT FÜR PSYCHIATRISCHE PHÄNOMIK UND GENOMIK
CAMPUS INNENSTADT
9CME
Punkte
Dear colleagues,
It is a great pleasure to invite you to the 5th Munich Kraepelin Symposium on Thursday 20th of October 2016 at the Department of Psychiatry and Psy-chotherapy, Medical Center of the University of Munich.
The symposium was initiated in 1997 by Hans-Jürgen Möller in order to ack-nowledge the scientific and clinical excellence on Emil Kraepelin, chairman of the Department of Psychiatry and Psychotherapy from 1904 to 1922.
The current 5th symposium is dedicated to the topic of recovery in psycho-ses. We will make an attempt to reappraise the concept of recovery, discuss its molecular underpinnings and define current options to improve recovery in severe mental disorders, e.g. psychoses.
We are looking forward to welcoming you to Munich to the 5th Munich Krae-pelin Symposium. We sincerely hope that you will be able to enjoy the topics and boost your knowledge on recovery and its underpinnings in psychoses.
Prof. Dr. Peter Falkai Prof. Dr. Thomas G. SchulzeDirector of the Department of Director of the Institute ofPsychiatry and Psychotherapy Psychiatric Phenomics and Genomics
5. Münchener Kraepelin-Symposium 5
Thursday, 20.10.2016
8.45 Welcome P. Falkai / T.G. Schulze
Conceptual reappraisal of „remission“ and „recovery“
9.00 – 9.30 S. Galderisi (Naples, Italy) Reviewing the concept of remission and recovery in psycho-ses: What should we achieve?
9:30 – 10.00 W. Fleischhacker (Innsbruck, Austria) Cohort studies in psychoses: Did recovery improve over the last decades?
10.00 - 10.30 Atalay Alem (Addis Ababa, Ethiopia) Course and outcome of schizophrenia in Butajira, a rural district in Ethiopia
10.30 - 11.00 E. Chen (Hong Kong, China) Are first episode psychosis programs helpful to improve outcome?
11.00 - 11.30 Coffee break
The clinical basis of recovery
11.30 – 12.00 M. Budde, T.G. Schulze, N. Müller, F. Theis Munich, Germany) Clinical trajectories in schizophrenia and bipolar disorders: novel insights into disorder specific and cross-diagnostic patterns of the long-term course
12.00 - 12.30 N. Koutsouleris (Munich, Germany) Predicting the outcome of schizophrenia
12.30 – 13.30 Lunch
5. Münchener Kraepelin-Symposium4
Thursday, 20.10.2016
Understanding the molecular basis of recovery
13.30 – 14.00 D. Öngür (Belmont, USA) Bioenergetics and oxidative stress: Relationship to long term outcomes in schizophrenia
14.00 - 14.30 A. Fischer (Göttingen, Germany) Early life events and methylation pattern: subtyping the long-term outcome of psychoses, in mice and humans
14.30 – 15.00 S. Wolter, O. Gruber (Heidelberg, Germany) Imaging biomarkers of the long-term course of affective and non-affective psychoses
15.00 - 15.30 U. Heilbronner (Munich, Germany) Neurobiological and cognitive aspects of long-term outcome in Schizophrenia: review and meta-analysis
15.30 - 16.00 O. Howes (London, England) The neurobiology of recovery and critical issues
16.00 - 16.30 Coffee break
Improving recovery in psychosis
16.30 - 17.00 S. Vinogradov (Minneapolis, USA) Distinct phenotypes of training-induced cognitive plasticity in psychoses
17.00 - 17.30 A. Hasan (Munich, Germany) Modulating outcome in schizophrenia using brain stimulation methods
17.30 - 18.00 M. Rossner (Munich, Germany) New drugs for remission: Finding the right pathway tto ent-rance remissoin
Thomas G. Schulze, M.D., Head and Professor of the Institute of Psychiatric Phenomics and Genomics (IPPG), Medical Center of the University of Munich, Nußbaumstr. 7, D-80336 Munich
Sophia Vinogradov, M.D., Head and Professor, Department of Psychiatry, F282/2A West-B, 8393A (Campus Delivery Code), 2450 Riverside Ave, Minneapolis, MN 55454, USA
List of speakers
Atalay Alem, MD, PhD, Professor, Department of Psychiatry, Addis Ababa University, Consultant Psychiatrist, Amanuel Hospital, P.O.Box 9086, Addis Ababa, Ethiopia
Monika Budde, Institute of Psychiatric Phenomics and Genomics (IPPG), Medical Center of the University of Munich, Nußbaumstr. 7, D-80336 Munich
Eric YH Chen, M.D., Head and Professor of the Department of Psychiatry, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China
Peter Falkai, M.D., Head and Professor of the Department of Psychiatry and Psychotherapy, Medical Center of the University of Munich, Nußbaumstr. 7, D-80336 Munich
André Fischer, M.D., Professor of the Department of Psychiatry and Psychotherapy, Georg August University, von-Siebold-Str. 5, D-37075 Göttingen
Wolfgang Fleischhacker, M.D., Professor and Head of the Department of Psychiatry and Psychotherapy, University Innsbruck, Anichstraße 35, 6020 Innsbruck, Austria
Silvana Galderisi, M.D., University of Naples SUN, Largo Madonna delle Grazie, 1, 80138 Naples Italy
Oliver Gruber, M.D., Professor of the Department of Psychiatry, Ruprecht-Karls University, Vossstraße 4, D-69115 Heidelberg
Alkomiet Hasan, M.D., Department of Psychiatry and Psychotherapy, Medical Center of the University of Munich, Nußbaumstr. 7, D-80336 Munich
Urs Heilbronner, Ph.D., Institute of Psychiatric Phenomics and Genomics (IPPG), Medical Center of the University of Munich, Nußbaumstr. 7, D-80336 Munich
Oliver Howes, M.D., Institute of Psychiatry, Box 67, Camberwell, London, SE5 8AF, United Kingdom
Nikolaos Koutsouleris, M.D., Department of Psychiatry and Psychotherapy, Medical Center of the University of Munich, Nußbaumstr. 7, D-80336 Munich
Dost Öngür, M.D., Ph.D., Chief of the Psychotic Disorders Division at McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA
Moritz Rossner, Dr. rer. nat., Professor in Molekulare Neurobiologie, Department of Psychiatry and Psychotherapy, Medical Center of the University of Munich, Nußbaumstr. 7, D-80336 Munich
Prof. Peter FalkaiDepartment of Psychiatry and Psychotherapy Medical Center of the University of Munich
Prof. Thomas G. SchulzeInstitute of Psychiatric Phenomics and Genomics (IPPG) Medical Center of the University of Munich)
Information Secretary: Frau Koelbert, Tel.: 0049-89-4400-55331; E-Mail: [email protected]
Certificated by the Baverian Landesärztekammer for physicians 9 CME-Punkte
Your participation is confirmed in the office of the conference and by offering your Barcode when registered by the BLÄK.
Conference venueLecture hall of the Department of Psychiatry and Psychotherapy, Medical Center of the University of Munich, Nussbamstr. 7, 80336 Munich
Registration
Klinik f. Psychiatrie u. Psychotherapie Klinikum der Universität München z.Hd. Frau K. Koelbert
Nußbaumstraße 7 D - 80336 München
FAX: *49/89/4400-54548
Name
Last Name
Adresse
Telefone
Fax
E-Mail
Participation form at the 5th Münchener Kraepelin-Symposium
